Page 3 - Altmed Capital Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altmed capital corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altmed Capital Corp Today - Breaking & Trending Today

New Rapid mood Screener Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need


Champignon Brands Inc. announces the publication of an article led by Dr. Roger McIntyre CEO of Champignon Brands Inc. The article The Rapid Mood Screener : a novel and pragmatic screener for bipolar I disorder – is published in Taylor and Francis.com . To review the Article, click here . Depressive episodes and symptoms of bipolar I disorder are commonly misdiagnosed as major depressive disorder in primary care. …
Champignon Brands Inc. (the “Company”), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announces the publication of an article led by Dr. Roger McIntyre CEO of Champignon Brands Inc. The article The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder – is published in Taylor and Francis.com . To review the Article, click here . ....

Rogers Mcintyre , Roger Mcintyre , University Of Toronto , University Health Network , Altmed Capital Corp , Champignon Brands Inc , Canadian Rapid Treatment Center , Champignon Brands , Rapid Mood Screener , Mood Disorders Psychopharmacology Unit , University Health , Altmed Capital , ரோஜர்ஸ் முசந்த்ிரே , ரோஜர் முசந்த்ிரே , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , பல்கலைக்கழகம் ஆரோக்கியம் வலைப்பின்னல் , கனடியன் விரைவான சிகிச்சை மையம் , பல்கலைக்கழகம் ஆரோக்கியம் ,

Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression


Share this article
Third CRTCE Clinic effectively addresses the unmet need of depression and suicide
VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ - Champignon Brands Inc. (the Company ), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the opening of a new Canadian Rapid Treatment Center of Excellence (
CRTCE) clinic in Ottawa, Ontario. This third clinic joins the Mississauga and Toronto clinics (CRTCE Clinics) in addressing the unmet need of depression and suicide through novel ketamine therapy treatment.
Over twenty clinical trials have demonstrated that ketamine and esketamine have rapid and robust antidepressant effects in patients that have failed to respond to conventional antidepressants. During the COVID-19 pandemic, the need for effective treatment has become exponentially critical, said Dr. Joshua Rosenblat, Medical Director, CRTCE. Ketamine treatment for depression is very difficult to access in Canada. This thi ....

British Columbia , Roger Mcintyre , Rogers Mcintyre , Kevin Kratiuk , Joshua Rosenblat , Pharmacology University Of Toronto , Altmed Capital Corp , Champignon Brands Inc , Canadian Rapid Treatment Center , Champignon Brands , Medical Director , Ketamine Infusions , Vice President , Brands Inc , Pharmacology University , Intravenous Ketamine Infusion Therapy , Intranasal Esketamine Therapy , Oral Ketamine Therapy , Altmed Capital , பிரிட்டிஷ் கொலம்பியா , ரோஜர் முசந்த்ிரே , ரோஜர்ஸ் முசந்த்ிரே , மருந்தியல் பல்கலைக்கழகம் ஆஃப் டொராண்டோ , கனடியன் விரைவான சிகிச்சை மையம் , மருத்துவ இயக்குனர் , கெட்டமைன் உட்செலுத்துதல் ,

Champignon Brands Announces New CFO and New General Counsel


Champignon Brands Announces New CFO and New General Counsel
News provided by
Share this article
Leadership of Chairman and CEO Dr. Roger McIntyre
VANCOUVER, BC, Jan. 11, 2021 /PRNewswire/ - Champignon Brands Inc. (the Company ),
(CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the Company s appointment of Stephen R. Brooks as its new Chief Financial Officer and Peter Rizakos as the firm s new General Counsel.
These appointments complete the Company s new top management team put into place by Dr. McIntyre and the Champignon Board of Directors.  Dr. McIntyre stated, these new management additions ready us for the future where the Company s clinical products and services will help meet the enormous public need that is creating significant public demand for improved, ketamine-based treatments that are capable of rapid response in persons with depression. ....

New York , United States , United Kingdom , British Columbia , Roger Mcintyre , Stephen Brooks , Chris Hobbs , Peter Rizakos , Toronto Blue Jays , Osgoode Hall Law School , University Of British Columbia , Canadian Securities Exchange , Champignon Brands Inc , Canadian Rapid Treatment Center , Rogers Centre , Law Society Of Ontario , Rogers Communications Inc , Harvard Business School , Osim International , Altmed Capital Corp , Champignon Canadian Rapid Treatment Centre Of Excellence , British Columbia Securities Commission , Rogers Media Inc , Appointments Complete New Top Management Team , Counsel For Marret Asset Management Inc , Chief Financial Officer ,